Non-neovascular AMD
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration (NCT06087458) | Perceive Biotherapeutics, Inc. | 2023-06-21 |
Track Non-neovascular AMD automatically
Every clearance here is in the API, with alerts when new ones post.